This week’s episode of “WisBusiness: The Podcast” features Tobias Zutz, founder and CEO of Madison-based Gregor Diagnostics.
He’s developing a method to test seminal fluid for signs of prostate cancer. Zutz is a former employee of Exact Sciences in Madison, which has a similar test for colorectal cancer which relies on stool samples.
“My background has always been R&D,” Zutz said. “I’ve been a bench-level scientist and worked there, so transitioning to more of a business-focused role, putting together a business plan, pitching to investors and getting money — that was all brand new to me.”
The startup has a license agreement with the Wisconsin Alumni Research Foundation, and completed a $900,000 funding round earlier this summer. Gregor Diagnostics recently moved from the 100state coworking space into the pilot space for Forward BIOLABS, and hired several employees.